DOD grant accelerates SARS-CoV-2 vaccine manufacturing

By The Science Advisory Board staff writers

March 24, 2020 -- The U.S. Department of Defense (DOD) has awarded Ology Bioservices and Inovio Pharmaceuticals an $11.9 million contract to rapidly manufacture DNA vaccines, the companies announced on March 24. Ology, a biologics contract development and manufacturing organization, will work with Inovio's DNA technology platform.

The grant is supported by the Office of the Assistant Secretary of Defense for Health Affairs with funding from the Defense Health Agency. It will enable the companies to work with Inovio's DNA vaccine (INO-4800) for protection against SARS-CoV-2 infection. The goal of the program is to rapidly and efficiently deliver the vaccine to the Department of Defense for upcoming clinical trials.

The combination of Ology's manufacturing resources and expertise and Inovio's promising vaccine candidate will enable the companies to offer a vaccine to protect the U.S. military and the entire nation against current and future disease outbreaks, according to the companies.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here